The diagnosis of EDKA can be challenging due to its atypical presentation, and it is important to consider this diagnosis in patients with unexplained metabolic acidosis, especially those on SGLT2 inhibitors
Our treatments are designed for fast, safe, and lasting results so you can see and feel the difference in just a few sessions
Cyanocobalamin : Helps address vitamin B12 deficiency that can cause fatigue, weakness, and low energy
The exception: in March 2024, the FDA approved a supplemental indication for semaglutide 2.4 mg (Wegovy) to reduce the risk of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke in adults with established cardiovascular disease and either obesity or overweight (SELECT trial, Lincoff et al., New England Journal of Medicine 2023)